PMID: 7334071Apr 1, 1981Paper

Impaired antibody responses to a pneumococcal polysaccharide vaccine in patients with non-Hodgkin's lymphoma in remission

Journal of Clinical Immunology
O F BallesterC L Burek

Abstract

Eight patients with non-Hodgkin's lymphoma who have been in complete clinical remission for the mean of 23.3 months were evaluated for their antibody responses to a pneumococcal vaccine. The results were correlated with lymphocyte subpopulations, serum immunoglobulin levels, and in vitro mitogenic responses to phytohemagglutinin, concanavalin and pokeweed mitogen. Two patients with normal antibody responses had immunoglobulin levels and mitogenesis within the range of controls. Impaired antibody responses in the remaining six patients were correlated either with marked depressed mitogenesis to phytohemagglutinin or with low levels of IgA. Impaired humoral immune responses seem to persist in these patients even after several months of sustained clinical remission.

References

Aug 31, 1978·The New England Journal of Medicine·G R SiberG Schiffman
Sep 1, 1979·British Journal of Cancer·P L Amlot, L Green
Aug 1, 1977·British Journal of Urology·M A JewettW F Whitmore
Mar 22, 1975·British Medical Journal·A VollerE Engvall
Sep 4, 1975·The New England Journal of Medicine·J E Sokal
Mar 1, 1961·Proceedings of the Society for Experimental Biology and Medicine·S SASLAWB BOURONCLE

❮ Previous
Next ❯

Citations

Feb 1, 1994·Acta Odontologica Scandinavica·D StrömS Holm

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.